drugset / Trial / NCT06848231
A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a Phase 2, double-blind, placebo-controlled, multi-center, Phase II, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and efficacy of Ya-101 in subjects with multiple system atrophy.
Timeline
- Start
- 2025-03-03
- Primary completion
- 2026-06-30
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | YA-101 | Unknown | — | — |